BioSolveIT And Cambridge Crystallographic Data Centre Release World Class Fragments for Top Quality Drug design

ST. AUGUSTIN, Germany & CAMBRIDGE, England--(BUSINESS WIRE)--BioSolveIT GmbH in conjunction with The Cambridge Crystallographic Data Centre (CCDC) today announced the release of an exclusive set of fragments for 3D-based computational drug design. The Cambridge Structural Database (CSD) is a key global source for crystal structures and a major resource for the chemical and pharmaceutical industries. It provides the basis for the highest quality input fragment data for successful fragment-based lead discovery (FBLD) with LeadIT. Dr. Colin Groom, Executive Director of the CCDC said that “Precise crystal structure data is crucial for underpinning knowledge-based applications software. The CCDC is committed to combining the strengths of the CSD with third-party applications, and we are very pleased to be working with BioSolveIT in this capacity.”

Back to news